To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Arlington Capital invests in injectable drugs maker Afton Scientific
Tom Thorpe, founder and CEO of Afton, will continue to lead the company and remain a material shareholder going forward.
